Know Labs (NYSEAMERICAN:KNW) Trading 3.8% Higher – Still a Buy?

Shares of Know Labs, Inc. (NYSEAMERICAN:KNW) were up 3.8% during trading on Tuesday . The stock traded as high as $2.17 and last traded at $2.1390. Approximately 612,050 shares traded hands during mid-day trading, an increase of 60% from the average daily volume of 381,756 shares. The stock had previously closed at $2.06.

Know Labs Trading Up 3.8%

The company has a market cap of $16.04 million, a PE ratio of -0.33 and a beta of 1.83. The business has a 50 day simple moving average of $2.14 and a two-hundred day simple moving average of $2.14.

Institutional Investors Weigh In On Know Labs

Several hedge funds have recently modified their holdings of the stock. Bard Financial Services Inc. purchased a new position in shares of Know Labs in the 3rd quarter worth about $80,000. Corient Private Wealth LLC purchased a new stake in Know Labs during the second quarter worth approximately $99,000. Finally, Cerity Partners LLC acquired a new stake in shares of Know Labs in the second quarter worth $158,000. 23.96% of the stock is owned by institutional investors and hedge funds.

Know Labs Company Profile

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.